Neuroprotective effects of ropinirole against nicotine- and ethanol-induced cognitive impairment, oxidative stress, neuroinflammation, and neurodegenerative alterations in rats.
Azizi Omid O, Ghasemi Reza R, Kakhki Samaneh S, Etebari Maryam M et al.
Adolescence is a critical period of brain development during which exposure to addictive substances may adversely affect cognitive function and neuronal plasticity. Combined nicotine and ethanol exposure may contribute to persistent cognitive impairment through disturbances in oxidative balance, inflammatory signaling, and hippocampal function. However, the potential effects of pharmacological interventions targeting these alterations after exposure remain insufficiently characterized. Given the previously reported neuroprotective properties of ropinirole, this study investigated whether post-exposure treatment with this dopamine D2/D3 receptor agonist could attenuate cognitive deficits and associated hippocampal biochemical alterations in rats subjected to adolescent nicotine-ethanol co-exposure. Male Wistar rats were exposed to nicotine (2 mg/kg/day, intraperitoneally) and ethanol (20% v/v in drinking water) during adolescence (postnatal days 21-48). Following the exposure period, animals received oral ropinirole at doses of 5, 10, or 20 mg/kg/day for three weeks. Spatial learning and memory and recognition memory were assessed using the Morris water maze and novel object recognition tests, respectively. Hippocampal biochemical assessments included malondialdehyde (MDA), nitrite, total thiol content, superoxide dismutase (SOD), catalase, tumor necrosis factor-α (TNF-α), interleukin-10 (IL-10), brain-derived neurotrophic factor (BDNF), acetylcholinesterase (AChE), and amyloid-β (Aβ). Nicotine-ethanol co-exposure significantly impaired spatial learning, memory retention, and recognition memory, accompanied by increased hippocampal MDA, nitrite, TNF-α, AChE activity, and Aβ levels, together with reduced antioxidant capacity, IL-10, and BDNF expression. Post-exposure ropinirole treatment improved performance in the behavioral tests and attenuated several of the associated biochemical alterations. The 20 mg/kg dose generally showed the most pronounced effects among the doses tested; however, a formal dose-response relationship was not established. These findings suggest that ropinirole exerts neuroprotective effects against adolescent nicotine-ethanol-induced cognitive impairment through the modulation of oxidative stress, neuroinflammation, cholinergic dysfunction, neurotrophic signaling, and amyloid-related pathways. These results provide preliminary evidence supporting dopaminergic modulation as a potential strategy for mitigating substance-associated cognitive dysfunction, although further mechanistic and translational studies are necessary.